Watch Ticker

Aclaris Therapeutics, Inc.

Go to Aclaris Therapeutics, Inc. Website

$1.54

-0.02 (-0.96%)

Live

Previous Close

$1.56

Day Range

$1.532 - $1.6

Previous Day Range

$1.5 - $1.56

Market Cap

$165.7 million USD

Day Vol.

267212

Previous Day Vol.

666338

Currency

USD

Primary Exchange

Nasdaq

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two reportable segments: therapeutics ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Aclaris Therapeutics to Participate in the HC Wainwright “HCW@Home” Series

Aclaris Therapeutics, a clinical-stage biopharmaceutical company, announced its Q1 2025 financial results and provided a corporate update. The company's CEO and senior leadership team will participate in a virtual fireside chat.

Related tickers: ACRS.

Read Full Article

N/A - Aclaris Therapeutics Appoints Jesse Hall, M.D. as Chief Medical Officer

Aclaris Therapeutics, a clinical-stage biopharmaceutical company, has appointed Jesse Hall, M.D. as its new Chief Medical Officer. Dr. Hall's extensive experience in areas like immunology and antibody development will be crucial in leading Aclaris' clinical strategy for its portfolio of immuno-inflammatory product candidates.

Related tickers: ACRS.

Read Full Article

Trending Tickers

Please sign in to view